Cite
MLA Citation
S Luo et al.. “Soluble urokinase-type plasminogen activator receptor (suPAR) is associated with risk for thromboembolic complications and mortality in patients with COVID-19.” European heart journal, vol. 42, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100144497453.0x000042